This website uses cookies to enhance the user experience.
ABILIA AS

ABILIA AS936 869 335

Purchase and sale
Limited company
Tevlingveien 23 1081 OSLO, Norge
Goods and trade
/ Purchase and sale
/ 46.460 Wholesale of pharmaceutical goods

ABILIA AS

Keywords

pharmaceuticalshospital equipmentorthopedic articles

Links

Organization

CEO
TE

Tove Emma Caroline Christiansson1971

Chairman of the board
TE

Tove Emma Caroline Christiansson1971

Years since formation
30 years
since Feb 19, 1995
Type
Limited company
VAT registered
Yes
Number of employees
30

Ownership

Number of shares and share classes
2,000
1 share class
Total number of shareholders
1
person
Belongs to group of

Financials

Total operating income 2024
192,306,398
NOK
Annual total result 2024
13,652,275
NOK
Total equity 2024
55,353,647
NOK
Last update: Jul 9, 2025

Management

Management / administration

NameRoleShares
TE

Tove Emma Caroline Christiansson

1971

Managing Director/CEO-

Board

NameRoleShares
TE

Tove Emma Caroline Christiansson

1971

Chairman-

Others

NameRoleShares
K
KPMG AS
Auditor-
A
ACCOUNTOR AS
Accountant-
Last update: May 23, 2025

Ownership

Company shareholders

NameShare classTotal number of sharesShare
SH

Sverige Holding Ab Abilia

Ordinary shares
2,000
100 %

Shares owned by the ABILIA AS

NameShare classTotal number of sharesShare
K
KOMPANY AS
Ordinary shares
100,000
100 %
P
PICOMED AS
Ordinary shares
1,000
100 %
C
COGNITA AS
Ordinary shares
2,000
100 %
Last update: Jun 2, 2025

Group structure

  • ABILIA AS
    Total operating income 2024: NOK 192,306,398
    Operating profit 2024: NOK 14,949,558
    Employees: 30

Financials

in NOK

Summary

Year2024202320222021
Total operating income
192,306,398
145,637,520
109,313,147
92,654,520
Annual Total Result
13,652,275
52,739,919
31,549,442
25,079,240
Total assets
152,860,331
112,057,264
88,224,580
77,760,137
Total liabilities
97,506,684
70,355,875
59,263,110
49,348,110
Total equity
55,353,647
41,701,388
28,961,470
28,412,028

P&L

Year2024202320222021
Total operating income
192,306,398
145,637,520
109,313,147
92,654,520
Total operating costs
177,356,840
79,916,598
69,818,216
61,281,843
Operating result
14,949,558
65,720,923
39,494,931
31,372,677
Financial income/costs
2,608,372
1,927,109
981,229
795,969
Profit before tax
17,557,930
67,648,031
40,476,159
32,168,646
Total tax & extraordinary income/cost
3,905,655
14,908,112
8,926,717
7,089,406
Annual Total Result
13,652,275
52,739,919
31,549,442
25,079,240

Balance overview

Year2024202320222021
Total fixed assets
90,523,325
53,984,190
21,723,076
23,237,409
Total current assets
62,337,007
58,073,073
66,501,504
54,522,729
Total assets
152,860,331
112,057,264
88,224,580
77,760,137
Short term debt
97,325,003
70,112,889
58,984,266
48,993,000
Long term debt
181,681
242,986
278,844
355,110
Total liabilities
97,506,684
70,355,875
59,263,110
49,348,110
Contributed capital
2,875,000
2,875,000
2,875,000
2,875,000
Retained earnings
52,478,647
38,826,388
26,086,470
25,537,028
Total equity
55,353,647
41,701,388
28,961,470
28,412,028
Total equity and liabilities
152,860,331
112,057,264
88,224,580
77,760,137

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
G
Main industrial area
Wholesale and retail trade; repair of motor vehicles and motorcycles
46
Activity
Wholesale trade, except of motor vehicles and motorcycles
46.4
Main industrial group
Wholesale of household goods
46.46
Industrial group
Wholesale of pharmaceutical goods
46.460
Industrial group
Wholesale of pharmaceutical goods